PAR paradigm biopharmaceuticals limited..

What do they want?, page-5

  1. 10,383 Posts.
    lightbulb Created with Sketch. 1414
    The rat study is one I refer back to regularly to highlight the extraordinary DM priorities of PPS

    "......Common findings between the two treatment approaches included reduced serum inflammatory markers, improved dentition and skull lengths, reduced tracheal deformities, and improved mobility."
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
42.0¢
Change
-0.020(4.55%)
Mkt cap ! $166.9M
Open High Low Value Volume
44.5¢ 44.5¢ 41.5¢ $271.6K 637.8K

Buyers (Bids)

No. Vol. Price($)
2 5960 42.0¢
 

Sellers (Offers)

Price($) Vol. No.
43.0¢ 3696 1
View Market Depth
Last trade - 16.10pm 16/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.